Skip to content
Catalyst

metforminPapers

Papers about metformin

papers
3,985
41 years, by papers

Newest first

3,951 to 3,985 of 3,985

Every paper here, unless its row says otherwiseIndexed under metformin in PubMed's chemical list; returned by a PubMed search for metformin

  • One year comparative trial of metformin and glipizide in type 2 diabetes mellitus.

    Diabete & metabolisme1994PMID 7843470

  • Antihyperglycaemic efficacy, response prediction and dose-response relations of treatment with metformin and sulphonylurea, alone and in primary combination.

    Diabetic medicine1994PMID 7895460

  • Obese patients with type 2 diabetes poorly controlled by insulin and metformin: effects of adjunctive dexfenfluramine therapy on glycaemic control.

    Diabetic medicine1994PMID 7955998

  • Effects of metformin and metoprolol CR on hormones and fibrinolytic variables during a hyperinsulinemic, euglycemic clamp in man.

    Thrombosis and haemostasis1994PMID 7974348Indexed under metformin in PubMed's chemical list

  • Effects of metformin treatment on whole-body and splanchnic amino acid turnover in mild type 2 diabetes.

    The Journal of clinical endocrinology and metabolism1994PMID 7989455

  • Metabolic effects of metformin addition to chronic glibenclamide treatment in type 2 diabetes.

    Diabete & metabolisme1994PMID 8056129

  • Metformin and metoprolol CR treatment in non-obese men.

    Journal of internal medicine1994PMID 8151265Indexed under metformin in PubMed's chemical list

  • Metformin improves glucose, lipid metabolism, and reduces blood pressure in hypertensive, obese women.

    Diabetes care1993PMID 8269798

  • Metabolic and hemodynamic effects of metformin and glibenclamide in normotensive NIDDM patients.

    Diabetes care1993PMID 8359098

  • Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors.

    European journal of clinical pharmacology1993PMID 8453955

  • Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups.

    Diabetes care1993PMID 8462390

  • The effect of intravenous metformin on glucose metabolism during hyperglycaemia in type 2 diabetes.

    Diabetic medicine1992PMID 1551312

  • Metformin normalizes nonoxidative glucose metabolism in insulin-resistant normoglycemic first-degree relatives of patients with NIDDM.

    Diabetes1992PMID 1551495

  • Prospective comparative study in NIDDM patients of metformin and glibenclamide with special reference to lipid profiles.

    European journal of clinical pharmacology1991PMID 1748145

  • The insulin sparing effect of metformin in insulin-treated diabetic patients.

    Diabete & metabolisme1991PMID 1834486

  • Effects of metformin and glibenclamide alone and in combination on serum lipids and lipoproteins in patients with non-insulin-dependent diabetes mellitus.

    Diabete & metabolisme1991PMID 1936472

  • Effects of metformin on dyslipoproteinemia in non-insulin-dependent diabetes mellitus.

    Diabete & metabolisme1991PMID 1936474

  • Comparative efficacy of metformin and glibenclamide in patients with non-insulin-dependent diabetes mellitus.

    Diabete & metabolisme1991PMID 1936477

  • Comparative three-month study of the efficacies of metformin and gliclazide in the treatment of NIDD.

    Diabete & metabolisme1991PMID 1936478

  • Prospective randomized two-years clinical study comparing additional metformin treatment with reducing diet in type 2 diabetes.

    Diabete & metabolisme1991PMID 1936479

  • Treatment strategies for secondary sulfonylurea failure. Should we start insulin or add metformin? Is there a place for intermittent insulin therapy?

    Diabete & metabolisme1991PMID 1936480

  • Treatment of NIDDM patients with secondary failure to glyburide: comparison of the addition of either metformin or bed-time NPH insulin to glyburide.

    Diabete & metabolisme1991PMID 1936482

  • Sulfonylurea-metformin-combination versus sulfonylurea-insulin-combination in secondary failures of sulfonylurea monotherapy. Results of a prospective randomized study in 50 patients.

    Diabete & metabolisme1991PMID 1936483

  • BIGPRO (biguanides and the prevention of the risk of obesity): study design. A randomized trial of metformin versus placebo in the correction of the metabolic abnormalities associated with insulin resistance.

    Diabete & metabolisme1991PMID 1936485

  • Double-blind evaluation of efficacy and tolerability of metformin in NIDDM.

    Diabetes care1991PMID 2060439

  • Betaxolol and glucose-insulin relationships: studies in normal subjects taking glibenclamide or metformin.

    British journal of clinical pharmacology1990PMID 2125460Returned by a PubMed search for metformin

  • Comparison of tolbutamide and metformin in elderly diabetic patients.

    Diabetic medicine1990PMID 2142054

  • Placebo-controlled trial of the effects of guar gum and metformin on fasting blood glucose and serum lipids in obese, type 2 diabetic patients.

    Diabetic medicine1990PMID 2158410

  • Metformin-induced changes in serum lipids, lipoproteins, and apoproteins in non-insulin-dependent diabetes mellitus.

    Atherosclerosis1990PMID 2193640

  • Cholesterol lowering effect of metformin in combined hyperlipidemia: placebo controlled double blind trial.

    Annals of medicine1990PMID 2291838

  • The hyperlactatemic effect of biguanides: a comparison between phenformin and metformin during a 6-month treatment.

    Rivista europea per le scienze mediche e farmacologiche1989PMID 2798990

  • Metformin decreases the high plasminogen activator inhibition capacity, plasma insulin and triglyceride levels in non-diabetic obese subjects.

    Thrombosis and haemostasis1987PMID 3310318

  • Effects of metformin treatment on erythrocyte insulin binding in normal weight subjects, in obese non diabetic subjects, in type 1 and type 2 diabetic patients.

    Diabete & metabolisme1986PMID 3533670

  • Bioavailability of metformin. Comparison of solution, rapidly dissolving tablet, and three sustained release products.

    International journal of clinical pharmacology, therapy, and toxicology1986PMID 3710634

  • Metformin improves peripheral vascular flow in nonhyperlipidemic patients with arterial disease.

    Journal of cardiovascular pharmacology1984PMID 6209500

← Previous 50